Semiconductor startup Sophrosyne Technologies raises $2 million from Bluehill VC

Semiconductor startup Sophrosyne Technologies has raised $2 million in seed funding from Chennai-based Bluehill VC to take its health-focussed chip technology to the next stage of development.

The Bengaluru-based startup is developing a biosensing system-on-chip (SoC) that can track ECG, PPG, breathing, temperature, and other signals in wearable devices while consuming less power.

"By consolidating multiple sensing functions into one compact architecture, the company enables wearable devices to deliver richer and more continuous health insights with a smaller silicon footprint," the startup said.


The new capital will be used to move from prototype silicon to full development, expand the engineering team, and begin early customer deployments in India and global markets. The startup also recently secured a $1.2 million MeitY Design Linked Incentive (DLI) grant after clearing technical checks under the government’s semiconductor design scheme.

“Wearable health is entering a new phase where accuracy and continuous monitoring are becoming standard expectations,” said Sridhar Parthasarathi, managing partner at Bluehill VC. He added that Sophrosyne is solving practical problems for device makers, especially around power use and system complexity.

Manish Srivastava, cofounder and CEO of Sophrosyne, said the funding comes at an important time for the company. “We are moving toward production-grade silicon and early rollouts with OEMs. Bluehill’s semiconductor expertise will help us scale globally,” he said.